Conference - Cambridge, MA, United States
Phenotypic screening (aka classical Drug Discovery) has been historically used in drug discovery. While technological developments have made the prevalence of target-based screening more popular, statistical analysis shows that a disproportionate number of first-in-class drugs with novel mechanisms of action come from phenotypic screening. Cambridge Healthtech Institute’s Inaugural Phenotypic Drug Discovery meeting will address the advantages of phenotypic screening vs. target-based screening, and focus on assay development, selection of physiologically-relevant models and subsequent target identification
Organization: Cambridge Healthtech Institute
(Courtesy of www.fastcongress.com/Phenotypic-Drug-Discovery)
October 28, 2013 - October 29, 2013, 09:00 - 17:00 (GMT-05:00) Eastern Time (US & Canada)
Le Méridien Cambridge-MIT, 20 Sidney Street, Cambridge, MA, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
